Pfizer, Inc. (PFE) Stock Forecasts

Argus Senior Analyst David H. Toung has published a report on Pfizer Inc. (PFE), highlighting strong growth from the company's non-COVID products. The report provides a summary of Pfizer's position as a leading developer of pharmaceuticals and biotech drugs, including oncology, immunology, rare disease treatments, and vaccines. Access to the full report and premium research requires an upgrade.